GENE ONLINE|News &
Opinion
Blog

2026-02-08|

Eco-Friendly Zinc Nanoparticles Synthesized Using Beetroot Peel Extract Show Antibacterial and Photocatalytic Properties

by GOAI
Share To

Researchers have developed an eco-friendly method to synthesize star-shaped zinc nanoparticles using Beta vulgaris (beetroot) peel extract. The study evaluates the antibacterial, photocatalytic, and cytotoxic properties of these nanoparticles, highlighting their potential applications in various fields. The findings demonstrate the effectiveness of utilizing natural plant extracts for nanoparticle synthesis as a sustainable alternative to conventional chemical methods.

The research outlines the process of synthesizing zinc nanoparticles through green chemistry techniques involving beetroot peel extract. The study reports that these nanoparticles exhibit significant antibacterial activity against certain bacterial strains, suggesting their potential use in antimicrobial treatments. Additionally, the photocatalytic performance of the nanoparticles was tested under specific conditions, showing promising results for environmental applications such as pollutant degradation. Cytotoxicity assessments were also conducted to evaluate their safety profile, providing insights into possible biomedical uses. This approach emphasizes sustainability by reducing reliance on harmful chemicals while exploring multifunctional properties of zinc nanoparticles synthesized from natural sources.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: February 16, 2026

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
LATEST
Oragenics Submits Annual Report Highlighting Fiscal Year 2025 Financials and Research Updates
2026-03-17
SurgePays Launches Nationwide Campaign to Promote LinkUp Mobile Service
2026-03-17
Tempus and Blood Cancer United Collaborate to Build Extensive Pediatric AML Data Registry
2026-03-17
Two RXO Leaders Earn Fourth Consecutive Recognition in Supply Chain Pros to Know Awards
2026-03-17
Pfizer Reports Phase 2 Trial Success for Atirmociclib in Second-Line Metastatic Breast Cancer Treatment
2026-03-17
Merck to Present Long-Term Efficacy Data on GARDASIL9 and GARDASIL at EUROGIN 2026
2026-03-17
AECOM Consortium Selected for Initial Phase of £200 Million STEP Fusion Energy Program
2026-03-17
Scroll to Top